enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. ‘A huge shock to the system’: Doctors warn about asthma ...

    www.aol.com/huge-shock-system-doctors-warn...

    GSK did price the authorized generic lower than branded Flovent; one package of Flovent HFA in the 110 microgram dose, for example, costs $273.83, about 50% more than the $177.99 wholesale ...

  3. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

    www.aol.com/news/popular-asthma-inhaler...

    The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...

  4. List of withdrawn drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_withdrawn_drugs

    Diversion, abuse, and a relatively high rate of overdose deaths in comparison to other drugs of its group. This drug continues to be available in most of the world including the US, but under strict controls. Terfenadine (Seldane, Triludan) 1997–1998 France, South Africa, Oman, others, US Prolonged QT interval; ventricular tachycardia [2] [3]

  5. Since then, GSK has conducted additional pre-clinical research and, after assessing various options, has elected to discontinue further development of GSK2251052 and return all rights to ...

  6. Fluticasone - Wikipedia

    en.wikipedia.org/wiki/Fluticasone

    Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. [1] [2] [3] [4] [5] Both the esters, fluticasone propionate (sold as Flovent) and ...

  7. Fluticasone/salmeterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone/salmeterol

    Other side effects from this drug combination may include increased blood pressure, change in heart rate, an irregular heartbeat, increased risk of osteoporosis, cataracts, and glaucoma. [2] Studies have demonstrated the safety of inhaled fluticasone propionate in children.

  8. Fluticasone furoate/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

    In 2013, the drug was approved for use in the United States by the Food and Drug Administration (FDA) for long-term maintenance treatment of airflow obstruction in people with COPD, including chronic bronchitis and emphysema, [6] and the European Medicines Agency approved it as a second-line therapy for the treatment of COPD and asthma. [7]

  9. GlaxoSmithKline Dives on Weak Growth - AOL

    www.aol.com/2012/04/25/glaxosmithkline-dives-on...

    LONDON -- "Big pharma" giant GlaxoSmithKline (NYS: GSK) slightly disappointed its owners today, as its latest results revealed low growth in turnover and earnings. GSK's slow growthAs soon as GSK ...